3

PRIMARY DOCUMENT

Company: Viridian Therapeutics, Inc.\DE
Filed: June 17, 2014
Period of Report: June 17, 2014
Accession Number: 0001382963-14-000032

View Document ↗ View on SEC.gov ↗